SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Anticipation is surging for SELLAS Life Sciences' pivotal Phase 3 REGAL trial results for its AML immunotherapy, GPS, with community discussion highlighting strong confidence in potential "curative outcomes" as evidence suggests patients are living longer than expected, fueling speculation of a massive short squeeze.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending following a significant Q4 earnings and revenue beat, driven by accelerating Miplyffa sales that have ignited community optimism around the company's commercial transformation and potential European expansion. However, active discussions also highlight persistent concerns over management's long-term vision, historical stock performance, and the financial implications of a recent adverse legal ruling.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

Relmada Therapeutics is surging following impressive 12-month Phase 2 data for its bladder cancer treatment, NDV-01, showing a durable 76% complete response rate and securing $160 million in financing for Phase 3. The community is buzzing with excitement over the clinical progress and funding, actively debating whether the significant momentum and volume can drive sustained gains.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY saw a significant intraday rally driven by President Trump's declarations that the war in Iran is "pretty much complete," though community sentiment is split between those seizing on the rebound and skeptics warning of a "scam pump" amidst ongoing geopolitical and oil market uncertainty.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is trending due to a recently closed $40 million private placement and a research collaboration with GSK, igniting a fervent short-squeeze narrative among traders and leading to speculative price targets while others warn of a sharp reversal given the private placement's lower valuation.

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals (XENE) is experiencing a significant surge following exceptionally strong Phase 3 X-TOLE2 trial results for its epilepsy treatment, azetukalner, which surpassed expectations and positions the drug as a differentiated Kv7 potassium channel opener. The market is buzzing with excitement over the robust efficacy, even as some investors react to a subsequent common shares offering.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending as its Juniper Networks acquisition solidifies its competitive stance in AI-native hybrid cloud and networking, sparking community discussions about its market potential. Investors are highlighting HPE's strengthened portfolio, robust AI server demand, and raised full-year guidance as key drivers, despite some cautious near-term revenue forecasts.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is trending due to recent strong earnings results that outperformed expectations, coupled with an optimistic fiscal year outlook and ongoing strategic expansion plans. The community is actively discussing the company's resilient "pizza and gas" business model and its valuation as it continues to grow within the convenience store sector.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending after securing critical regulatory approvals in the US, EU, and UK for its high-purity graphene, paving the way for immediate commercialization. The community is highly optimistic, anticipating substantial purchase orders, an upcoming Nasdaq uplisting, and views HGRAF's unique technology as a foundational material set to revolutionize numerous industries.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is experiencing extreme volatility as President Trump's comments about the Iran war being "very complete" and ships resuming passage through the Strait of Hormuz counter earlier concerns of escalating conflict and production cuts, which initially sent prices soaring. The community is deeply divided, with some actively shorting on hopes of de-escalation and strategic oil reserve releases, while others remain bullish, citing ongoing geopolitical risks and the critical importance of the Strait to global oil supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Microreactor Race Is On

The Microreactor Race Is On Authored by Duggan Flanakin via RealClearEnergy, For the past half century, successive Presidential administrations and the Nuclear Regulatory Commission have thwarted the...

HCM II Acquisition (NASDAQ:IMSR) Shares Up 8.2% - Here's Why

HCM II Acquisition (NASDAQ:IMSR) Shares Up 8.2% - Here's Why...

Northland Securities Predicts IMSR FY2025 Earnings

HCM II Acquisition Corp. (NASDAQ:IMSR - Free Report) - Investment analysts at Northland Securities issued their FY2025 earnings estimates for HCM II Acquisition in a research report issued on...

HCM II Acquisition (NASDAQ:IMSR) Earns Outperform Rating from Analysts at Northland Securities

Northland Securities began coverage on HCM II Acquisition in a research note on Thursday. They issued an "outperform" rating and a $15.00 target price on the stock...

Cooling towers of a nuclear power plant in Oxford, UK.

IMSR Stock Headed For Third Straight Day Of Gains? Retail Calls It 'Oklo 2.0'

Terrestrial Energy is a nuclear energy company that’s beginning to captivate retail traders and investors alike.

Equity

HCM II Acquisition Sees Unusually Large Options Volume (NASDAQ:IMSR)

HCM II Acquisition Corp. (NASDAQ:IMSR - Get Free Report) was the target of unusually large options trading activity on Monday. Traders bought 13,479 call options on the company. This is an increase...

This Small-Cap Nuclear Stock Bombed At Debut — But 2026 Might Be Its Redemption Year

A DOE deal, nuclear-friendly policy signals, and roaring retail chatter are propelling IMSR’s comeback.

Why Terrestrial Energy Stock May See A Redemption In 2026 After Rough Debut Last Year

A DOE deal, nuclear-friendly policy signals, and roaring retail chatter are propelling IMSR’s comeback.


Terrestrial Energy Secures DOE Deal To Fast-Track Advanced Nuclear Reactor Project

Terrestrial Energy Inc. stock surged after securing federal agreement for clean, reliable nuclear power technology with quicker deployment.read more...

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

<ul class="summary-bullets"><li>The company said that it is targeting the plant deployment as part of the DOE’s accelerated authorization of pilot TETRA reactor operation.</li><li>Terrestrial Energy will directly collaborate with the DOE to review and authorize the design and safe operation of the TETRA reactor.</li><li>The Advanced Reactor Pilot Program allows the DOE to authorize private companies to build reactors outside its national laboratories.</li></ul>Terrestrial Energy Inc. (IMSR) shares rose over 22% on Tuesday morning after the company executed an agreement with the U.S. Department of Energy (DOE).Terrestrial Energy said it has signed an agreement for Project TETRA, a DOE initiative to construct and operate a pilot reactor that will support the development of the Integral Molten Salt Reactor (IMSR) plant.The company said that it is targeting the plant deployment as part of the DOE’s accelerated authorization of pilot TETRA reactor operation.<h2 class="st-heading-2">Collaboration With DOE</h2>Terrestrial Energy stated that as part of the agreement, it will directly collaborate with the DOE to review and authorize the design and safe operation of the TETRA reactor.“The agreement sits on our development center-path, allowing the company to expedite key elements of its program to prepare licensing applications for commercial plant operation,” said Terrestrial Energy CEO Simon Irish.The Advanced Reactor Pilot Program allows the DOE to authorize private companies to build reactors outside its national laboratories.<h2 class="st-heading-2">What Does Terrestrial Energy Do?</h2>Terrestrial Energy is a Charlotte, North Carolina-based company engaged in developing fourth-generation nuclear plants using its proprietary IMSR design.IMSR plants are designed to be small and modular, while allowing them to be used for the dual-use energy role relevant for data center operations, as well as industrial applications such as petrochemical and chemical synthesis.The company said it is engaging with regulators to license and commission the first IMSR plants in the early 2030s.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/IMSR">Terrestrial Energy</a> soared on Tuesday to enter the ‘extremely bullish’ territory after being in the ‘bearish’ zone a day ago. Message volumes also surged, rising to ‘extremely high’ levels from ‘normal’ levels a day ago.One bullish Stocktwits user thinks the IMSR stock is due for a “few 100 percent” days.<stembedurl>https://stocktwits.com/Big_Joe96/message/640930049</stembedurl>Another user thinks the stock still has a long way to go. The IMSR stock is down 72% from its 52-week high of $31.5.<stembedurl>https://stocktwits.com/jtstox/message/640928071</stembedurl><a href="https://stocktwits.com/symbol/IMSR">IMSR stock</a> is up 38% year-to-date, but down 16% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-alms-stock-rising-today/cmxwvW3R4Tk">Why Is ALMS Stock Rising Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is IMSR Stock Rising Today?

Terrestrial Energy said it has signed an agreement for Project TETRA, a DOE initiative to construct and operate a pilot reactor that will support IMSR plant development.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Current Price	$6.72
Prev Close	$6.49
Open	$6.29
Dividend Yield	0.00%
50-Day Moving Average	$8.29
Beta	0.62
Avg. Volume	1.81M
PE Ratio	33.26

52-Week High	$31.50
52-Week Low	$5.95
Market Capitalization	$530.7M
EPS (Annual)	$0.1186
Price to Book	0.82
Revenue Per Employee	N/A

IMSR
Terrestrial Energy Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IMSR News

IMSRTerrestrial Energy Inc.